A widespread issue of image manipulation by suppliers of research antibodies is raising concerns about the reliability of scientific research. The practice, which would warrant retraction of a scientific paper if done by researchers themselves, involves alterations to images used to promote and sell antibodies.
According to a report, image changes that would get a paper retracted are widespread among suppliers. These alterations aren't accidental; they are deliberate attempts to make antibodies appear to work better than they do. The issue centers on Western blots, a common laboratory technique used to detect specific proteins. Suppliers are manipulating these images to highlight the presence of a target protein, even when the antibody doesn’t bind strongly or at all.
This practice is particularly troubling because researchers rely on these images to decide which antibodies to purchase. A misleading image can lead to wasted resources, flawed experiments, and ultimately, incorrect scientific conclusions. The report doesn't specify which companies are involved, but notes the problem is pervasive across the industry. The motivation is purely commercial: to increase sales by presenting a more favorable picture of product performance.
While researchers are expected to critically evaluate data and controls, the sheer volume of antibodies available and the reliance on supplier-provided images can make it difficult to detect these manipulations. The report highlights a significant gap in quality control and transparency within the research supply industry.
Read the original coverage
💬 Comments
📜 Comment Policy